In a bold move to tackle one of the most formidable cancers, Anocca AB has announced the submission of a Clinical Trial Application (CTA) to the European Medicines Agency (EMA) for their innovative VIDAR-1 Phase I/II multi-asset trial, targeting advanced pancreatic cancer. The pioneering trial, set
The launch of an advanced cell restoration treatment in Thailand marks a significant milestone in the Thai-Japan partnership. NihonChojyu Clinic, established by Dr. Masatoshi Egoshi, is at the forefront of this healthcare innovation, emphasizing the restoration of health and beauty from the
Recent research has uncovered a startling discovery: certain rare genetic mutations in the breast cells of healthy women may be early indicators of breast cancer development. This groundbreaking study, conducted by researchers from the University of British Columbia (UBC), BC Cancer, Harvard
The intricate dance between viruses and the host cells they infect has always been a subject of intense scientific inquiry. Recent research into SARS-CoV-2, the virus at the heart of the COVID-19 pandemic, has revealed a sophisticated mechanism through which this pathogen manipulates host
Stéphanie Gauvin and Tim MacIsaac, a devoted couple hailing from Nova Scotia, have embarked on a challenging and emotional journey to save their five-year-old golden doodle, Lucy, diagnosed with T-cell lymphoma. In their quest to find the best possible treatment for Lucy, they have encountered
Engineered virus-like particles (eVLPs) are revolutionizing the field of gene delivery and editing. These particles are designed to safely and effectively deliver macromolecules, such as mRNAs, proteins, or ribonucleoproteins (RNPs), into cells. While Adeno-associated virus (AAV) vectors have been
